Abstract
Interferon-α (IFN-α) inhibits the replication of hepatitis B virus (HBV) in vivo and in vitro, but the molecular mechanism of this inhibition has been elusive. We found that while HBV replication in transfected human hepatoma Huh-7 cell was severely inhibited by IFN-α treatment as reported previously, this inhibition was markedly impaired in the cell in which the expression of IFN-inducible, double-stranded RNA-dependent protein kinase (PKR) was stably and specifically suppressed through RNA-interference. Intracellular level of viral capsids was down-regulated likewise in a PKR-dependent manner, whereas that of HBV transcripts including the viral RNA pregenome was not affected by IFN-α treatment. Ectopic expression of PKR also resulted in the reduction of viral capsids with concomitant increase of phosphorylated eIF2α. These results suggested that PKR functions as a key mediator of IFN-α in opposing HBV replication, most likely through the inhibition of protein synthesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cha, M.Y., Kim, C.M., Park, Y.M., and Ryu, W.S. (2004). Hepatitis B virus X protein is essential for the activation of Wnt/betacatenin signaling in hepatoma cells. Hepatology 39, 1683–1693.
Darnell, J.E., Jr. (1997). STATs and gene regulation. Science 277, 1630–1635.
Garcia, M.A., Meurs, E.F., and Esteban, M. (2007). The dsRNA protein kinase PKR: virus and cell control. Biochimie 89, 799–811.
Guidotti, L.G., Morris, A., Mendez, H., Koch, R., Silverman, R.H., Williams, B.R., and Chisari, F.V. (2002). Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 76, 2617–2621.
Hayashi, Y., and Koike, K. (1989). Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA. J. Virol. 63, 2936–2940.
Hoofnagle, J.H., and di Bisceglie, A.M. (1997). The treatment of chronic viral hepatitis. N. Engl. J. Med. 336, 347–356.
Kang, J.I., Kwon, S.N., Park, S.H., Kim, Y.K., Choi, S.Y., Kim, J.P., and Ahn, B.Y. (2009). PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control. Virus Res. 142, 51–56.
Katze, M.G., He, Y., and Gale, M., Jr. (2002). Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675–687.
Langland, J.O., Cameron, J.M., Heck, M.C., Jancovich, J.K., and Jacobs, B.L. (2006). Inhibition of PKR by RNA and DNA viruses. Virus Res. 119, 100–110.
Lok, A.S., and McMahon, B.J. (2007). Chronic hepatitis B. Hepatology 45, 507–539.
Ohata, K., Ichikawa, T., Nakao, K., Shigeno, M., Nishimura, D., Ishikawa, H., Hamasaki, K., and Eguchi, K. (2003). Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells. FEBS Lett. 553, 304–308.
Pasquetto, V., Wieland, S.F., Uprichard, S.L., Tripodi, M., and Chisari, F.V. (2002). Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J. Virol. 76, 5646–5653.
Proud, C.G. (1995). PKR: a new name and new roles. Trends Biochem. Sci. 20, 241–246.
Rang, A., Gunther, S., and Will, H. (1999). Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J. Hepatol. 31, 791–799.
Robek, M.D., Wieland, S.F., and Chisari, F.V. (2002). Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J. Virol. 76, 3570–3574.
Samuel, C.E. (1993). The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268, 7603–7606.
Seeger, C., Zoulim, F., and Mason, W.S. (2007). Hepadnaviruses. Field’s virology, D.M., Knipe, and P.M. Howley, eds. (Philadelphia, USA: Lippincott Williams & Wilkins), pp. 2977–3029.
Sohn, S.Y., Kim, S.B., Kim, J., and Ahn, B.Y. (2006). Negative regulation of hepatitis B virus replication by cellular Hsp40/DnaJ proteins through destabilization of viral core and X proteins. J. Gen. Virol. 87, 1883–1891.
Su, H., and Yee, J.K. (1992). Regulation of hepatitis B virus gene expression by its two enhancers. Proc. Natl. Acad. Sci. USA 89, 2708–2712.
Uprichard, S.L., Wieland, S.F., Althage, A., and Chisari, F.V. (2003). Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc. Natl. Acad. Sci. USA 100, 1310–1315.
Wieland, S.F., Guidotti, L.G., and Chisari, F.V. (2000). Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J. Virol. 74, 4165–4173.
Wieland, S.F., Eustaquio, A., Whitten-Bauer, C., Boyd, B., and Chisari, F.V. (2005). Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl. Acad. Sci. USA 102, 9913–9917.
Xu, C., Guo, H., Pan, X.B., Mao, R., Yu, W., Xu, X., Wei, L., Chang, J., Block, T.M., and Guo, J.T. (2010). Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J. Virol. 84, 9332–9340.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
About this article
Cite this article
Park, IH., Baek, KW., Cho, EY. et al. PKR-dependent mechanisms of interferon-α for inhibiting hepatitis B virus replication. Mol Cells 32, 167–172 (2011). https://doi.org/10.1007/s10059-011-1059-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-011-1059-6